Obesity in patients with acute lymphoblastic leukemia in childhood

Italian Journal of Pediatrics

Volumn 38, Issue 1, 2012, Pages

  Iughetti, Lorenzo ^a   Bruzzi, Patrizia ^a   Predieri, Barbara ^a   Paolucci, Paolo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Acute lymphoblastic leukemia; children; metabolic syndrome; obesity

Indexed keywords

CORTICOSTEROID; LEPTIN; GROWTH HORMONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; BODY MASS; CALORIC INTAKE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CHILDHOOD DISEASE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOTHALAMUS DISEASE; LIFESTYLE; METABOLISM; OBESITY; PHYSICAL ACTIVITY; RADIATION DOSE; REVIEW; RISK FACTOR; WEIGHT GAIN; CHILD; COMORBIDITY; ENERGY METABOLISM; HYPOTHALAMUS; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIATION EXPOSURE; RADIOTHERAPY; SURVIVOR;

BODY MASS INDEX; CHILD; COMORBIDITY; ENERGY METABOLISM; GROWTH HORMONE; HUMANS; HYPOTHALAMUS; LEPTIN; LIFE STYLE; METABOLIC SYNDROME X; OBESITY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RADIOTHERAPY; RISK FACTORS; SURVIVORS; WEIGHT GAIN;

EID: 84860557656     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: 10.1186/1824-7288-38-4     Document Type: Review

References (79)

1. Acute lymphoblastic leukaemia. Pui CH Robison LL, Look AT, Lancet 2008 371 1030 1043 10.1016/S0140-6736(08)60457-2 18358930 (Pubitemid 351389536)
2. Chronic health conditions in adult survivors of childhood cancer. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL, Childhood Cancer Survivor Study, N Engl J Med 2006 355 1572 82 10.1056/NEJMsa060185 17035650 (Pubitemid 44547808)
3. A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL). Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL, Eur J Cancer Care 2005 14 1 53 62 10.1111/j.1365-2354. 2005.00513.x (Pubitemid 40314386)
4. Temporal trends in the incidence of childhood leukemia, lymphomas and solid tumors in north-west Italy, 1967-2001. A report of the Childhood Cancer Registry of Piedmont. Dalmasso P, Pastore G, Zuccolo L, Maule MM, Pearce N, Merletti F, Magnani C, Haematologica 2005 90 1197 1204 16154843 (Pubitemid 41375280)
5. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. Smith MA, Seibel NL, Altekruse SF, Ries LA, Melbert DL, O'Leary M, Smith FO, Reaman GH, J Clin Oncol 2010 28 2625 2634 10.1200/JCO.2009.27.0421 20404250
6. Patterns of obesity in boys and girls after treatment for acute lymphoblastic leukaemia. Odame I, Reilly JJ, Gibson BES, Donaldson MDC, Arch Dis Child 1994 71 147 149 10.1136/adc.71.2.147 7944537 (Pubitemid 24261120)
7. Obesity after successful treatment of ALL in childhood. Van Dongen-Melman JE, Hokken-Koelaga AC, Hahlen K, De Groot A, Tromp CG, Egeler RM, Pediatr Res 1995 38 86 90 10.1203/00006450-199507000-00015 7478803
8. Anthropometric parameters and their relationship to serum growth hormone-binding protein and leptin levels in children with acute lymphoblastic leukemia: a prospective study. Arguelles B, Barrios V, Buno M, Madero L, Argente J, Eur J Endocrinol 2000 143 243 250 10.1530/eje.0.1430243 10913944 (Pubitemid 30622359)
9. Weight patterns in children with higher risk ALL: a report from the children's oncology group (COG) for CCG 1961. Withycombe JS, Post-White JE, Meza JL, Hawks RG, Smith LM, Sacks N, Seibel NL, Pediatr Blood Cancer 2009 53 1249 1254 10.1002/pbc.22237 19688832
10. Therapy-related changes in body size in Hispanic children with acute lymphoblastic leukemia. Baillargeon J, Langevin AM, Lewis M, Grady JJ, Thomas PJ, Mullins J, Estrada J, Pitney A, Sacks N, Pollock BH, Cancer 2005 103 1725 1729 10.1002/cncr.20948 15754333 (Pubitemid 40490035)
11. High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood. Didi M, Didcock E, Davies HA, Ogilvy-Stuart AL, Wales JK, Shalet SM, J Pediatr 1995 127 1 63 67 10.1016/S0022-3476(95) 70258-X 7608813
12. Prevalence of obesity in children after therapy for acute lymphoblastic leukemia. Zee P, Chen CH, Am J Pediatr Hematol Oncol 1986 8 294 299 10.1097/00043426-198624000-00005 3467602 (Pubitemid 17229761)
13. Weight gain and height velocity during prolonged first remission from ALL. Sainsbury CPQ, Newcombe RG, Hughes IA, Arch Dis Child 1985 60 832 836 10.1136/adc.60.9.832 3863545 (Pubitemid 15238208)
14. Changes in body composition after childhood cancer treatment: impact on future health status-a review. Brouwer CAJ, Gietema JA, Kamps WA, de Vries EGE, Postma A, Crit Rev Oncol Hematol 2007 63 32 46 10.1016/j.critrevonc.2007.01.007 17344062 (Pubitemid 46810278)
15. Lung function and exercise capacity in survivors of childhood leukaemia. Jenney ME, Faragher EB, Jones PH, Woodcock A, Med Pediatr Oncol 1995 24 4 222 30 10.1002/mpo.2950240403 7700166
16. Childhood leukemia: a model of pre-obesity. Ventham JC, Reilly JJ, Proc Nutr Soc 1999 58 277 281 10.1017/S0029665199000385 10466167
17. Body composition of long-term survivors of acute lymphoblastic leukaemia. Warner JT, Evans WD, Webb DK, Gregory JW, Med Pediatr Oncol 2002 38 165 72 10.1002/mpo.1304 11836715 (Pubitemid 34171070)
18. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study. Marinovic D, Dorgeret S, Lescoeur B, Alberti C, Noel M, Czernichow P, Sebag G, Vilmer E, Leger J, Pediatrics 2005 116 102 8 10.1542/peds.2004-1838 15995009
19. Energy intake and basal metabolic rate during maintenance chemotherapy. Bond SA, Han AM, Wootton SA, Kohler JA, Arch Dis Child 1992 67 2 229 32 10.1136/adc.67.2.229 1543386
20. Nutritional status of children with acute lymphoblastic leukemia: a longitudinal study. Delbecque-Boussard L, Gottrand F, Ategbo S, Nelken B, Mazingue F, Vic P, Farriaux JP, Turck D, Am J Clin Nutr 1997 65 1 95 100 8988919 (Pubitemid 27020465)
21. Growth and body composition in response to chemotherapy in children with acute lymphoblastic leukemia. Halton JM, Atkinson SA, Barr RD, Int J Cancer 1998 11 81 84
22. Acute lymphoblastic leukemia and obesity: increased energy intake or decreased physical activity? Jansen H, Postma A, Stolk RP, Kamps WA, Support Care Cancer 2009 17 103 106 10.1007/s00520-008-0531-0 18989711
23. Sexually dimorphic and radiation dose dependent effect of cranial irradiation on body mass index. Craig F, Leiper AD, Stanhope R, Brain C, Meller ST, Nussey SS, Arch Dis Child 1999 81 500 504 10.1136/adc.81.6.500 10569967
24. GH deficiency caused by cranial irradiation during childhood: factors and markers in young adults. Adan L, Trivin C, Sainte-Rose C, Zucker JM, Hartmann O, Brauner R, J Clin Endocrinol Metab 2001 86 5245 5251 10.1210/jc.86.11.5245 11701685 (Pubitemid 33070243)
25. Precocius and premature puberty associated with treatment of acute lymphoblastic leukemia. Leiper AD, Stanhope R, Kitching P, Chessells JM, Arch Dis Child 1987 62 1107 12 10.1136/adc.62.11.1107 3479948 (Pubitemid 17151868)
26. Longitudinal growth and final height in long-term survivors of childhood leukemia. Cicognani A, Cacciari E, Rosito P, Eur J Pediatr 1994 153 726 30 10.1007/BF01954488 7813529 (Pubitemid 24300471)
27. Obesity in adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. Oeffinger KC, Mertens AC, Sklar CA, Yasui Y, Fears T, Stovall M, Vik TA, Inskip PD, Robison LL, Childhood Cancer Survivor Study, J Clin Oncol 2003 21 1359 1365 10.1200/JCO.2003.06.131 12663727 (Pubitemid 46606416)
28. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Sklar CA, Mertens AC, Walter A, Mitchell D, Nesbit ME, O'Leary M, Hutchinson R, Meadows AT, Robison LL, Med Pediatr Oncol 2000 35 91 5 10.1002/1096-911X(200008)35: 2<91::AID-MPO1>3.0.CO;2-G 10918229
29. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. Link K, Moell C, Garwicz S, Cavallin-Stahl E, Bjork J, Thilen U, Ahren B, Erfurth EM, J Clin Endocrinol Metab 2004 89 5003 5012 10.1210/jc.2004-0126 15472198 (Pubitemid 39391441)
30. Degree of fatness after treatment for acute lymphoblastic leukemia in childhood. Nysom K, Holm K, Michaelsen KF, Hertz H, Muller J, Molgaard C, J Clin Endocrinol Metab 1999 84 4591 4596 10.1210/jc.84.12.4591 10599724
31. Body composition in young adult survivors of childhood acute lymphoblastic leukaemia. Jarfelt M, Lannering B, Bosaeus I, Johannsson G, Bjarnason R, Eur J Endocrinol 2005 153 81 9 10.1530/eje.1.01931 15994749 (Pubitemid 41030519)
32. Body composition in children in remission from acute lymphoblastic leukemia. Murphy AJ, Wells JCK, Williams JE, Fewtrell MS, Davies PS, Webb DK, Am J Clin Nutr 2006 83 70 74 16400052 (Pubitemid 44699237)
33. Effect of chemotherapy on the energy and protein metabolism of children near the end of treatment for acute lymphoblastic leukemia. Vaisman N, Stallings VA, Chan H, Weitzman SS, Clarke R, Pencharz PB, Am J Clin Nutr 1993 57 5 679 84 8480686 (Pubitemid 23132803)
34. Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia. Birkebaek NH, Clausen N, Arch Dis Child 1998 79 161 164 10.1136/adc.79.2.161 9797600 (Pubitemid 28384853)
35. An anthropometric study of children during intensive chemotherapy for acute lymphoblastic leukemia. Ahmed SF, Wallace WH, Kelnar CJ, Horm Res 1997 48 4 178 183 10.1159/000185510 9378464 (Pubitemid 27403986)
36. Pattern and timing of weight gain in Scottish children treated for acute lymphoblastic leukemia. Ventham J, Reilly JJ, Dinaldson MDC, Gibson BES, Proceedings of the Nutrition Society 1998 57 334
37. Longitudinal changes in obesity and body mass index among adults survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. Garmey EG, Liu Q, Sklar CA, Meacham LR, Mertens AC, Stovall MA, Yasui Y, Robinson LL, Oeffinger KC, J Clin Oncol 2008 26 4639 4645 10.1200/JCO.2008.16.3527 18824710
38. Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma. Razzouk BI, Rose RS, Hongeng S, Wallace D, Smeltzer MP, Zacher M, Pui CH, Hudson MM, J Clin Oncol 2007 25 11833 1187
39. Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment. Dalton VK, Rue M, Silverman LB, Gelber RD, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin M, Tarbell NJ, Sallan SE, Cohen LE, J Clin Oncol 2003 21 2953 2960 10.1200/JCO.2003.03.068 12885815 (Pubitemid 46621847)
40. Auxological changes in UK survivors of childhood acute lymphoblastic leukemia treated without cranial irradiation. Breene RAL, Williams RM, Hartle J, Gattens M, Acerini CL, Murray MJ, Br J Cancer 2011 104 746 747 10.1038/bjc.2011.16 21326239
41. Adiposity in childhood cancer survivors: insights into obesity physiopathology. Siviero-Miachon AA, Spinola-Castro AM, Guerra-Junior G, Arq Bras Endocrinol Metab 2009 53 2 190 200
42. Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. Talvensaari KK, Lanning M, Tapanainen P, Knip M, J Clin Endocrinol Metab 1996 81 3051 3055 10.1210/jc.81.8.3051 8768873 (Pubitemid 26323907)
43. Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Birkebaek NH, Fisker S, Clausen N, Tuovinen V, Sindet-Pedersen S, Christiansen JS, Med Pediatr Oncol 1998 30 351 356 10.1002/(SICI)1096-911X(199806)30:6<351::AID-MPO9>3.0.CO;2-D 9589084 (Pubitemid 28198930)
44. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Gurney JG, Ness KK, Sibley SD, O'Leary M, Dengel DR, Lee JM, Youngren NM, Glasser SP, Baker KS, Cancer 2006 107 1303 12 10.1002/cncr.22120 16894525 (Pubitemid 44452780)
45. A longitudinal study of growth and growth hormone secretion in children during treatment for acute lymphoblastic leukemia. Marky L, Mellander L, Lannering B, Albertsson-Wikland K, Med Pediatr Oncol 1991 19 258 264 10.1002/mpo.2950190409 2056970
46. Osteopenia, excess adiposity and hyperleptinaemia during 2 years of treatment for childhood acute lymphoblastic leukaemia without cranial irradiation. Davies JH, Evans BA, Jones E, Evans WD, Jenney ME, Gregory JM, Clin Endocrinol (Oxf) 2004 60 358 65 10.1111/j.1365-2265.2003.01986.x (Pubitemid 38297127)
47. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Bostrom BC, Sensel MR, Sather HN, Gaynon PS, La MK, Johnston K, Erdmann GR, Gold S, Heerema NA, Hutchinson RJ, Provisor AJ, Trigg ME, Blood 2003 101 3809 3817 10.1182/blood-2002-08-2454 12531809 (Pubitemid 36857851)
48. Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia. Reilly JJ, Brougham M, Montgomery C, Richardson F, Kelly A, Gibson BE, J Clin Endocrinol Metab 2001 86 3742 3745 10.1210/jc.86.8.3742 11502805 (Pubitemid 32755970)
49. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, Krenning EP, de Muinck Keizer-Schrama SM, Med Pediatr Oncol 2000 35 415 20 10.1002/1096-911X(20001001)35:4<415::AID- MPO4>3.0.CO;2-9 11025472
50. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia. van Beek RD, de Muinck Keizer-Schrama SM, Hakvoort-Cammel FG, van der Sluis IM, Krenning EP, Pieters R, van den Heuvel-Eibrink MM, Pediatr Blood Cancer 2006 46 88 93 10.1002/pbc.20437 15926166 (Pubitemid 41779323)
51. Influence of treatment modalities on body weight in acute lymphoblastic leukemia. Groot-Loonen JJ, Otten BJ, van't Hof MA, Lippens RJ, Stoelinga GB, Med Pediatr Oncol 1996 27 2 92 97 10.1002/(SICI)1096-911X(199608)27:2<92::AID- MPO5>3.0.CO;2-O 8649326 (Pubitemid 26198775)
52. Adiposity rebound in children: a simple indicator for predicting obesity. Rolland-Cachera MF, Sempe M, Guillard-Bataille M, Am J Clin Nutr 1984 34 129 135
53. Patterns of growth associated with the timing of adiposity rebound. Williams SM, Goulding A, Obesity 2008 17 335 341 19057527
54. Factors associated with early adiposity rebound. Dorosty AR, Emmett PM, Cowin IS, Reilly JJ, Pediatrics 2000 105 1115 1118 10.1542/peds.105.5.1115 10790472 (Pubitemid 30243793)
55. Premature adiposity rebound in children treated for acute lymphoblastic leukemia. Reilly JJ, Kelly A, Ness P, Dorosty AR, Wallace WHB, Gibson BE, Emmett PM, ALSPAC Study Team, J Clin Endocrinol Metab 2001 86 2775 2778 10.1210/jc.86.6.2775 11397886 (Pubitemid 32545738)
56. Leptin and clinical medicine: a new piece in the puzzle of obesity. Bray GA, York DA, J Clin Endocrinol Metab 1997 82 2771 2776 10.1210/jc.82.9.2771 9284693 (Pubitemid 27385621)
57. Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia. Wallace AM, Tucker P, Williams DM, Hughes IA, Ahmed SF, Clin Endocrinol (Oxf) 2003 58 770 6 10.1046/j.1365-2265. 2003.01790.x (Pubitemid 36702738)
58. Hyperleptinemia in youngs adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity? Brennan BM, Rahim A, Blum FW, Adams JA, Eden OB, Shalet SM, Clin Endocrinol 1999 50 163 169 10.1046/j.1365-2265.1999.00622.x (Pubitemid 29100001)
59. Plasma levels of leptin and soluble leptin receptor and polymorphisms of leptin gene -18G > A and leptin receptor genes K109R and Q223R, in survivors of childhood acute lymphoblastic leukemia. Skoczen S, Tomasik P, Bik-Multanowski M, Surmiak M, Balwierz W, Pietrzyk JJ, Sztefko K, Gozdzik J, Galicka-Latala D, Strojny W, J Exp Clin Cancer Res 2011 30 64 73 10.1186/1756-9966-30-64 21631924
60. Late effects of childhood ALL treatment on body mass index and serum leptin levels. Karaman S, Ercan O, Yildiz I, Bolayirli M, Celkan T, Apak H, Ozkan A, Onal H, Canbolat A, J Pediatr Endocrinol Metab 2010 23 7 669 74 10.1515/JPEM.2010.23.7.669 20857839
61. Survivors of childhood acute lymphoblastic leukemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment. Bulow B, Link K, Ahren B, Wilsson AS, Erfwth EM, Clin Endocrinol (Oxf) 2004 61 683 691 10.1111/j.1365-2265.2004.02149.x (Pubitemid 40011843)
62. Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the childhhod cancer survivor study. Ross JA, Oeffinger KO, Davies SM, Mertens AC, Langer EK, Kiffmeyer WR, Sklar CA, Stovall M, Yasui Y, Robison LL, J Clin Oncol 2004 22 3558 3562 10.1200/JCO.2004.11.152 15337805 (Pubitemid 41103662)
63. A method of predicting adult height and obesity in long-term survivors of childhood acute lymphoblastic leukemia. Schell MJ, Ochs JJ, Schriock EA, Carter M, J Clin Oncol 1992 10 1 128 133 1727914
64. Body mass index in long-term adult survivors of childhood cancer. A report of the childhood cancer survivor study. Meacham LR, Gurney JG, Mertens AC, Ness KK, Sklar CA, Robison LL, Oeffinger KC, Cancer 2005 103 1730 1739 10.1002/cncr.20960 15761876 (Pubitemid 40490036)
65. Obesity in leukemia survivors: the familial contribution. Shaw MP, Bath LE, Duff J, Kelnar CJ, Wallace WH, Pediatr Hematol Oncol 2000 17 3 231 7 10.1080/088800100276406 10779989 (Pubitemid 30176717)
66. Relation of circumferences and skinfold thickness to lipid in children and adolescents: the Bogalusa Heart Study. Freedman DS, Serdula MK, Srinavasan SR, Berenson GS, Am J Clin Nutr 1999 69 308 317 9989697 (Pubitemid 29065556)
67. Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research. Kavey REW, Allada V, Daniels ST, Hayman LL, McCrindle BW, Newburger JW, Parekh RS, Steinberger J, Circulation 2006 114 2710 2738 10.1161/CIRCULATIONAHA.106.179568 17130340 (Pubitemid 46015982)
68. Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia. Oeffinger KC, Buchanan GR, Eshelman DA, Denke MA, Andrews TC, Germak JA, Tomlinson GE, Snell LE, Foster BM, J Pediatr Hematol Oncol 2001 23 424 430 10.1097/00043426-200110000-00007 11878576 (Pubitemid 33031770)
69. Detection of metabolic syndrome features among childhood cancer survivors: a target to prevent disease. Siviero-Miachon AA, Spinola-castro AM, Guerra-Junior G, Vasc Health Risk Manag 2008 4 4 825 836 19065999
70. Metabolic syndrome in children and adolescents with acute lymphoblastic leukemia after the completion of chemotherapy. Kourti M, Tragiannidis A, Makedou A, Papageorgiou T, Rousso I, Athanassiadou F, J Pediatr Hematol Oncol 2005 27 499 501 10.1097/01.mph.0000181428.63552.e9 16189445 (Pubitemid 41395905)
71. Obesity and hypertension among children after treatment for acute lymphoblastic leukemia. Chow EJ, Pihoker C, Hunt K, Wilkinson K, Friedman DL, Cancer 2007 110 2313 2320 10.1002/cncr.23050 17896787 (Pubitemid 350100754)
72. Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia. Janiszewski PM, Oeffinger KC, Church TS, Dunn AL, Eshelman DA, Victor RG, Brooks S, Turoff AJ, Sinclair E, Murray JC, Bashore L, Ross R, J Clin Endocrinol Metab 2007 92 10 3816 21 10.1210/jc.2006-2178 17652222 (Pubitemid 47607628)
73. Early indicators of dysmetabolic syndrome in young survivors of acute lymphoblastic leukemia in childhood as a target for preventing disease. Trimis G, Moschovi M, Papassotiriou I, Chrousos G, Tzortzatou-Stathopoulou F, J Pediatr Hematol Oncol 2007 29 5 309 14 10.1097/MPH.0b013e318059c249 17483708 (Pubitemid 46707511)
74. Obesity and outcome in pediatric acute lymphoblastic leukemia. Butturini AM, Dorey FJ, Lange BJ, Henry DW, Gaynon PS, Fu C, Franklin J, Siegel SE, Seibel NL, Rogers PC, Sather H, Trigg M, Bleyer WA, Carroll WL, J Clin Oncol 2007 25 2063 2069 10.1200/JCO.2006.07.7792 17513811 (Pubitemid 46972792)
75. Obesity in pediatric oncology. Rogers PC, Meacham LR, Oeffinger KC, Henry DW, Lange BJ, Pediatr Blood Cancer 2005 45 7 881 91 10.1002/pbc.20451 16035086 (Pubitemid 41552155)
76. World Cancer Research Fund and American Institute for Cancer Research Global Network. http://www.dietandcancerreport.org/cancer-resource-center/er- full-report-english.php
77. Risk factors for excess weight gain in children treated for acute lymphoblastic leukemia. Reilly JJ, Ventham JC, Int J Obes Relat Metab Disord 2000 24 1537 41 10.1038/sj.ijo.0801403 11126353
78. Energy expenditure, energy intake and prevalence of obesity after therapy for acute lymphoblastic leukemia during childhood. Mayer EI, Reuter M, Dopfer RE, Ranke MB, Horm Res 2000 53 4 193 9 10.1159/000023566 11044803
79. Obesity in long-term survivors of childhood acute lymphoblastic leukemia. Asner S, Ammann RA, Ozshahin H, Beck-Popovic M, von der Weid NX, Pediatr Blood Cancer 2008 51 112 118